APAC Regional Market Access Lead

dksh management pte. ltd.

Singapore

On-site

SGD 180,000 - 240,000

Full time

5 days ago

Be an early applicant

Get a reply from this employer

Your resume and cover letter, tailored to exactly what they’re hiring for.

Get past ATS filters

Job summary

DKSH Healthcare in Singapore seeks a Regional Market Access Manager to drive growth across Asia Pacific by embedding pricing, reimbursement, and evidence strategies into business development and portfolio decisions. You will build scalable regional access frameworks, coordinate with country teams, and lead innovative contracting models to improve patient access and commercial outcomes.

The role requires deep expertise in HTA, payer engagement, and market access across diverse Asia Pacific

Qualifications

Bachelor's degree in Pharmacy, Medicine, Health Sciences, Public Health, Health Economics, Economics, or a related discipline.
Postgraduate qualification in Health Economics, Outcomes Research, Public Health, Business Administration, or a related field is an advantage.
Proficiency in English; additional Asian language capability is an advantage.
At least 7 years of relevant experience in pharmaceutical, biotechnology, medical technology, healthcare consulting, payer, government, or market access roles.
Demonstrated experience in reimbursement strategy, payer engagement, formulary or reimbursement submissions, and launch access planning.
Regional or multi-country Asia Pacific experience, with practical understanding of differences in healthcare systems and access pathways.
Experience supporting asset evaluation, due diligence, business development, or revenue scenario development is strongly preferred.
Track record of working effectively with cross-functional and country teams in a matrix environment.
Experience with portfolio optimization, lifecycle management, or patient-access expansion initiatives is an advantage.
Hands-on experience with pricing strategy, payer negotiations, HTA interactions, innovative contracting, or evidence-generation planning is highly desirable.
Experience working with global or regional pharmaceutical partners and adapting global value strategies to heterogeneous Asia Pacific markets is an advantage.
Strong knowledge of healthcare systems, payer environments, reimbursement pathways, HTA, and formulary decision making across Asia Pacific markets.
Ability to assess market access potential and translate clinical, epidemiological, pricing, reimbursement, and market data into patient-access and revenue scenarios.
Proficiency in value proposition development, evidence strategy, reimbursement dossiers, budget-impact analysis, and payer communication.
Strong commercial and financial acumen, including scenario modelling and evaluation of assumptions, risks, and sensitivities.
Portfolio prioritization, launch planning, and project management capabilities across multiple countries and stakeholders.
Excellent analytical, problem-solving, and written communication skills, with the ability to communicate complex access topics clearly to senior stakeholders.
Strong influencing, facilitation, and stakeholder management capabilities in a matrix organization.
Strong understanding of pharmaceutical pricing strategy, pricing governance, launch sequencing, international reference pricing, tender dynamics, and contracting models.
Working knowledge of HEOR methods, real-world evidence, economic modelling, evidence synthesis, and critical appraisal of clinical and economic data.
Ability to plan and support payer, HTA, government, and institutional stakeholder engagement and negotiation in diverse cultural and policy environments.
Ability to convert cross-market payer and policy intelligence into clear implications for pipeline, portfolio, launch, and lifecycle decisions.
High standards of integrity, compliance, accuracy, and execution discipline.

Responsibilities

Develop and maintain a regional market access framework covering opportunity assessment, access pathway mapping, evidence requirements, reimbursement strategy, submission planning, and post-listing optimization, ensuring consistent adoption by business development and country teams.
Assess the market access attractiveness of future assets, including reimbursement feasibility, addressable patient segments, access timelines, pricing and funding considerations, and potential revenue scenarios, providing input into asset screening and business cases.
Conduct structured reviews of the existing DKSH Healthcare portfolio to identify where reimbursement and access interventions could expand patient reach and growth, prioritizing opportunities based on unmet need and commercial value.
Coordinate with country teams on market access plans for new product launches, including payer landscape assessment and evidence planning.
Lead regional pricing and reimbursement strategy for priority assets, including price corridor considerations and international reference pricing exposure.
Design and evaluate innovative access and contracting models, including managed-entry agreements and outcomes-based arrangements.
Support preparation of reimbursement and formulary submissions with appropriate clinical, economic, and budget-impact evidence.
Develop payer and HTA engagement strategies based on stakeholder mapping and evidence needs.
Partner with HEOR to shape integrated evidence-generation plans, including real-world evidence and budget impact analyses.
Adapt global value dossiers and payer materials for local relevance.
Build a regional view of payer developments and translate changes into implications for portfolios.
Act as a market access SME for pharmaceutical clients and partners, contributing to joint plans and governance forums.
Define post-listing optimization plans including formulary expansion and tender participation.
Set vision and roadmap for scalable regional market access capability and lead regional reviews.
Build market access capability within country teams through coaching and playbooks.
Administrative duties and coordination tasks as required.